
Information Technology · Application Software
$144.27
+3.71%
Vol: 87.2M
Friday, May 1, 2026
Palantir Technologies opened sharply higher on May 1, driven by positive sentiment ahead of its Q1 2026 earnings report scheduled for May 4. Revenue is expected to show strong growth from its AI strategy. The company has a $4.38 billion deal pipeline and operates at accelerating growth rates (70% YoY in Q4 2025). However, the stock is down 20% from recent highs and faces valuation concerns from some analysts like RBC.
PLTR secured multi-year $300M U.S. Department of Agriculture contract and announced strategic AI partnership with Cleveland-Cliffs (3-year deal deploying AI across operations). Q1 earnings due May 4, 2026; consensus expects EPS $0.28, revenue $1.54B (~74% YoY growth). Stock at $137.07 (market cap $330.1B) after recent 1.3% analyst downgrade but bullish outlook from Wedbush and Baird. Of 21 analysts: 14 Buy, 5 Hold, 2 Sell; avg PT $191.28 (35% upside). Stock down 20% YTD despite multi-year gains, but investors expecting earnings inflection. Risk: government contract delays, private sector adoption slower than expected.
Palantir secured three-year AI deployment deal with Cleveland-Cliffs Inc. (announced April 28) for production planning and operations. Q4 2025: US revenue +93% YoY, US commercial revenue +137% YoY. Company issued FY2026 revenue guidance of 61% YoY growth. Record total contract value exceeded $4.2B. DZ Bank initiated coverage (Buy, $175 PT); UBS upgraded from Neutral to Buy ($150 PT). Q1 2026 earnings release May 4 after close. Consensus expects $0.28 EPS, $1.54B revenue (74% YoY growth). Analyst consensus: Moderate Buy (14 Buy / 5 Hold / 2 Sell). Average PT $191.28 (35% upside). Current price $140.88. Stock down 19% YTD amid valuation concerns. FAA $32B contract bidding in final three.
Palantir Technologies reported exceptional Q4 2025 results with total revenue up 70% year-over-year, driven by U.S. revenue growth of 93%. The company closed 61 deals worth at least $10 million each and ended 2025 with $4.3 billion in total contract value, up 138% from the prior year. Customer count increased 34%. The company has become critical to U.S. military and intelligence operations, with President Trump recently endorsing Palantir by name. However, billionaire Michael Burry disclosed a substantial short position, citing Anthropic as competition. The stock is trading at $139.53 with a P/E multiple of 214.21.
Palantir stock surged on April 14-15 following Trump endorsement and a substantial 10-year Army software contract. Stock gained 3.03% closing at $136.05, rebounding from a 7% decline driven by Michael Burry bearish stance. Mizuho lowered price target to $185 from $195. Earnings report scheduled May 4, 2026.
Declined 7.3% on April 10 on monetization concerns. Expanded deals with Stellantis and GE Aerospace. Trump endorsed stock April 10. Michael Burry maintains short position.
Palantir Technologies fell 7.3% (April 8-9) as investor concerns mounted over competition from Anthropic Claude Mythos launch. Michael Burry criticized Palantir on April 10, noting Anthropic accelerated to $30B ARR offering cheaper alternatives. Stock down four consecutive days despite strong Q1 revenue of $1.41B (up 70% YoY) and Trump endorsement of military capabilities.
Palantir stock declined 6.6% after investor Michael Burry posted criticism claiming Anthropic is eating Palantir's lunch in enterprise AI. Burry cited Anthropic's revenue growth from $9B to $30B annually. Pullback coincided with Anthropic's new managed AI agents announcement. Palantir reported 70% YoY revenue growth in Q4 with 10 consecutive quarters of accelerating growth. Stock down 16% YTD.
Palantir Technologies shares fell 6.14% amid valuation concerns and regulatory scrutiny, despite securing a $10 billion, 10-year software contract with the US Army. The company reported Q4 FY2025 with 70% year-over-year revenue growth and beat earnings estimates by 19% with $0.25 EPS. AIP adoption continues to drive growth. Stock trades at $154.87 versus $185.25 analyst target, suggesting approximately 19% upside, though forward P/E of 112.85 remains elevated compared to industry average of 19.31.
Palantir disclosed renewed and expanded five-year Stellantis agreement to advance data and AI capabilities. PLTR shares declined nearly 5% today, dropping below $150 amid tech weakness and geopolitical concerns. Analyst sentiment bullish: 13 Buy, 4 Hold, 2 Sell. Average target $194.61 (32% upside).
Palantir reported 70% YoY revenue growth in Q4 2025 with 2025 full-year revenue of $4.48 billion (56.18% YoY increase). U.S. commercial revenue surged 109% to $1.465B while government grew 55% to $1.855B. DoD officially made Maven a program of record, significantly expanding utilization. Company renewed and expanded partnership with Stellantis. The Rule of 40 reached ~127% with ~50% margins. CEO outlined 10x revenue target to $40-45 billion by early 2030s. Consensus Buy rating targets $195.23 (31.50% upside). Stock trades $147.07, down 29% from $207 highs.
Palantir renewed and expanded five-year Stellantis partnership and secured Pentagon AI system designated program of record. Guiding US commercial revenue to exceed $3.144B in 2026 (115%+ growth). 22 analyst Buy ratings, $195.23 target (31.5% upside).
Palantir announced renewal and expansion of its partnership with Stellantis in a five-year agreement. The U.S. Department of Defense designated Palantir's Maven AI as a program of record, ensuring reliable, long-term federal funding. The company reported strong 2025 results with revenue up 56.18% to $4.48B and earnings up 251.59%. Analysts rate PLTR a Moderate Buy with average price target of $201.32 implying 37% upside. The stock is down 17% YTD.
Palantir Technologies announced a renewed and expanded five-year partnership with Stellantis involving broader use of Foundry and AI Platform for data management. The Pentagon also designated the company's Maven AI weapons-targeting platform as a program of record, transitioning from pilot to permanent budget-backed status across all U.S. military branches. Additionally, the UK Financial Conduct Authority awarded Palantir a three-month contract for fraud detection. The stock surged 6.87% as investors reacted positively to growth prospects. Total contract value reached $4.3 billion (up 138% YoY).
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| ORCLORACLE | $171.78 | +6.44% | +10.9% | 20.1x | 1.60 | $464.2B |
| PLTRPALANTIR | $144.27 | +3.71% | -6.0% | 74.6x | 1.67 | $333.5B |
| APPAPPLOVIN | $461.07 | +3.30% | +8.2% | 21.9x | 2.50 | $150.1B |
| CRMSALESFORCE | $184.10 | +4.29% | -4.6% | 11.8x | 1.29 | $144.4B |
| INTUINTUIT | $398.68 | +2.62% | -6.9% | 14.7x | 1.21 | $108.1B |
| ADBEADOBE | $250.47 | +1.78% | +0.7% | 9.3x | 1.52 | $99.5B |
Price below 200d MA — bearish structure.